Ryan Specialty (RYAN) Competitors

Ryan Specialty logo
$48.02 +0.17 (+0.34%)
As of 01:11 PM Eastern
This is a fair market value price provided by Massive. Learn more.

RYAN vs. AJG, BRO, WTW, ERIE, and HGTY

Should you buy Ryan Specialty stock or one of its competitors? Ryan Specialty's main competitors and comparable companies include Arthur J. Gallagher & Co. (AJG), Brown & Brown (BRO), Willis Towers Watson Public (WTW), Erie Indemnity (ERIE), and Hagerty (HGTY). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "insurance brokers" industry.

How does Ryan Specialty compare to Arthur J. Gallagher & Co.?

Arthur J. Gallagher & Co. (NYSE:AJG) and Ryan Specialty (NYSE:RYAN) are both large-cap finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, media sentiment, risk, profitability, analyst recommendations and valuation.

In the previous week, Arthur J. Gallagher & Co. had 9 more articles in the media than Ryan Specialty. MarketBeat recorded 17 mentions for Arthur J. Gallagher & Co. and 8 mentions for Ryan Specialty. Arthur J. Gallagher & Co.'s average media sentiment score of 1.06 beat Ryan Specialty's score of 0.63 indicating that Arthur J. Gallagher & Co. is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Arthur J. Gallagher & Co.
8 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Ryan Specialty
2 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Arthur J. Gallagher & Co. pays an annual dividend of $2.80 per share and has a dividend yield of 1.0%. Ryan Specialty pays an annual dividend of $0.52 per share and has a dividend yield of 1.1%. Arthur J. Gallagher & Co. pays out 42.8% of its earnings in the form of a dividend. Ryan Specialty pays out 64.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Arthur J. Gallagher & Co. has increased its dividend for 15 consecutive years and Ryan Specialty has increased its dividend for 1 consecutive years.

Arthur J. Gallagher & Co. has a beta of 0.47, suggesting that its share price is 53% less volatile than the broader market. Comparatively, Ryan Specialty has a beta of 0.54, suggesting that its share price is 46% less volatile than the broader market.

Arthur J. Gallagher & Co. currently has a consensus price target of $295.74, indicating a potential upside of 3.00%. Ryan Specialty has a consensus price target of $52.91, indicating a potential upside of 10.59%. Given Ryan Specialty's higher possible upside, analysts clearly believe Ryan Specialty is more favorable than Arthur J. Gallagher & Co..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Arthur J. Gallagher & Co.
0 Sell rating(s)
7 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.65
Ryan Specialty
1 Sell rating(s)
10 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.37

Arthur J. Gallagher & Co. has higher revenue and earnings than Ryan Specialty. Arthur J. Gallagher & Co. is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Arthur J. Gallagher & Co.$13.94B5.28$1.49B$6.5443.90
Ryan Specialty$3.05B3.95$63.40M$0.8159.07

Arthur J. Gallagher & Co. has a net margin of 10.39% compared to Ryan Specialty's net margin of 8.25%. Ryan Specialty's return on equity of 47.77% beat Arthur J. Gallagher & Co.'s return on equity.

Company Net Margins Return on Equity Return on Assets
Arthur J. Gallagher & Co.10.39% 13.90% 4.26%
Ryan Specialty 8.25%47.77%4.70%

85.5% of Arthur J. Gallagher & Co. shares are held by institutional investors. Comparatively, 84.8% of Ryan Specialty shares are held by institutional investors. 1.4% of Arthur J. Gallagher & Co. shares are held by company insiders. Comparatively, 52.0% of Ryan Specialty shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Arthur J. Gallagher & Co. beats Ryan Specialty on 12 of the 19 factors compared between the two stocks.

How does Ryan Specialty compare to Brown & Brown?

Ryan Specialty (NYSE:RYAN) and Brown & Brown (NYSE:BRO) are both large-cap finance companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, dividends, institutional ownership, profitability and valuation.

Ryan Specialty pays an annual dividend of $0.52 per share and has a dividend yield of 1.1%. Brown & Brown pays an annual dividend of $0.72 per share and has a dividend yield of 1.0%. Ryan Specialty pays out 64.2% of its earnings in the form of a dividend. Brown & Brown pays out 22.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Ryan Specialty has increased its dividend for 1 consecutive years. Ryan Specialty is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Brown & Brown had 2 more articles in the media than Ryan Specialty. MarketBeat recorded 10 mentions for Brown & Brown and 8 mentions for Ryan Specialty. Brown & Brown's average media sentiment score of 1.23 beat Ryan Specialty's score of 0.63 indicating that Brown & Brown is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ryan Specialty
2 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Brown & Brown
6 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Brown & Brown has higher revenue and earnings than Ryan Specialty. Brown & Brown is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ryan Specialty$3.05B3.95$63.40M$0.8159.07
Brown & Brown$5.90B4.14$1.05B$3.1623.29

Ryan Specialty currently has a consensus target price of $52.91, indicating a potential upside of 10.59%. Brown & Brown has a consensus target price of $76.12, indicating a potential upside of 3.44%. Given Ryan Specialty's stronger consensus rating and higher probable upside, equities research analysts clearly believe Ryan Specialty is more favorable than Brown & Brown.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ryan Specialty
1 Sell rating(s)
10 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.37
Brown & Brown
1 Sell rating(s)
13 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.33

84.8% of Ryan Specialty shares are owned by institutional investors. Comparatively, 71.0% of Brown & Brown shares are owned by institutional investors. 52.0% of Ryan Specialty shares are owned by insiders. Comparatively, 13.1% of Brown & Brown shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Brown & Brown has a net margin of 17.63% compared to Ryan Specialty's net margin of 8.25%. Ryan Specialty's return on equity of 47.77% beat Brown & Brown's return on equity.

Company Net Margins Return on Equity Return on Assets
Ryan Specialty8.25% 47.77% 4.70%
Brown & Brown 17.63%13.29%5.63%

Ryan Specialty has a beta of 0.54, indicating that its share price is 46% less volatile than the broader market. Comparatively, Brown & Brown has a beta of 0.52, indicating that its share price is 48% less volatile than the broader market.

Summary

Ryan Specialty and Brown & Brown tied by winning 10 of the 20 factors compared between the two stocks.

How does Ryan Specialty compare to Willis Towers Watson Public?

Ryan Specialty (NYSE:RYAN) and Willis Towers Watson Public (NASDAQ:WTW) are both large-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, earnings, risk and institutional ownership.

Ryan Specialty currently has a consensus price target of $52.91, suggesting a potential upside of 10.59%. Willis Towers Watson Public has a consensus price target of $373.11, suggesting a potential upside of 10.35%. Given Ryan Specialty's higher probable upside, equities research analysts plainly believe Ryan Specialty is more favorable than Willis Towers Watson Public.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ryan Specialty
1 Sell rating(s)
10 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.37
Willis Towers Watson Public
0 Sell rating(s)
6 Hold rating(s)
12 Buy rating(s)
1 Strong Buy rating(s)
2.74

Ryan Specialty has a beta of 0.54, meaning that its share price is 46% less volatile than the broader market. Comparatively, Willis Towers Watson Public has a beta of 0.44, meaning that its share price is 56% less volatile than the broader market.

Willis Towers Watson Public has higher revenue and earnings than Ryan Specialty. Willis Towers Watson Public is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ryan Specialty$3.05B3.95$63.40M$0.8159.07
Willis Towers Watson Public$9.71B3.21$1.61B$16.3920.63

Ryan Specialty pays an annual dividend of $0.52 per share and has a dividend yield of 1.1%. Willis Towers Watson Public pays an annual dividend of $3.84 per share and has a dividend yield of 1.1%. Ryan Specialty pays out 64.2% of its earnings in the form of a dividend. Willis Towers Watson Public pays out 23.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Ryan Specialty has increased its dividend for 1 consecutive years and Willis Towers Watson Public has increased its dividend for 8 consecutive years. Willis Towers Watson Public is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Willis Towers Watson Public has a net margin of 15.22% compared to Ryan Specialty's net margin of 8.25%. Ryan Specialty's return on equity of 47.77% beat Willis Towers Watson Public's return on equity.

Company Net Margins Return on Equity Return on Assets
Ryan Specialty8.25% 47.77% 4.70%
Willis Towers Watson Public 15.22%22.65%6.00%

84.8% of Ryan Specialty shares are held by institutional investors. Comparatively, 93.1% of Willis Towers Watson Public shares are held by institutional investors. 52.0% of Ryan Specialty shares are held by company insiders. Comparatively, 0.4% of Willis Towers Watson Public shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Willis Towers Watson Public had 2 more articles in the media than Ryan Specialty. MarketBeat recorded 10 mentions for Willis Towers Watson Public and 8 mentions for Ryan Specialty. Ryan Specialty's average media sentiment score of 0.63 beat Willis Towers Watson Public's score of 0.61 indicating that Ryan Specialty is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ryan Specialty
2 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Willis Towers Watson Public
2 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Willis Towers Watson Public beats Ryan Specialty on 13 of the 20 factors compared between the two stocks.

How does Ryan Specialty compare to Erie Indemnity?

Erie Indemnity (NASDAQ:ERIE) and Ryan Specialty (NYSE:RYAN) are both large-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, institutional ownership and media sentiment.

Erie Indemnity has a beta of 0.24, suggesting that its stock price is 76% less volatile than the broader market. Comparatively, Ryan Specialty has a beta of 0.54, suggesting that its stock price is 46% less volatile than the broader market.

Erie Indemnity has a net margin of 13.98% compared to Ryan Specialty's net margin of 8.25%. Ryan Specialty's return on equity of 47.77% beat Erie Indemnity's return on equity.

Company Net Margins Return on Equity Return on Assets
Erie Indemnity13.98% 20.53% 14.21%
Ryan Specialty 8.25%47.77%4.70%

Ryan Specialty has a consensus target price of $52.91, indicating a potential upside of 10.59%. Given Ryan Specialty's stronger consensus rating and higher possible upside, analysts clearly believe Ryan Specialty is more favorable than Erie Indemnity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Erie Indemnity
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Ryan Specialty
1 Sell rating(s)
10 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.37

Erie Indemnity has higher revenue and earnings than Ryan Specialty. Erie Indemnity is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Erie Indemnity$4.07B3.13$559.34M$11.0225.04
Ryan Specialty$3.05B3.95$63.40M$0.8159.07

33.7% of Erie Indemnity shares are owned by institutional investors. Comparatively, 84.8% of Ryan Specialty shares are owned by institutional investors. 45.8% of Erie Indemnity shares are owned by company insiders. Comparatively, 52.0% of Ryan Specialty shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Ryan Specialty had 5 more articles in the media than Erie Indemnity. MarketBeat recorded 8 mentions for Ryan Specialty and 3 mentions for Erie Indemnity. Ryan Specialty's average media sentiment score of 0.63 beat Erie Indemnity's score of 0.52 indicating that Ryan Specialty is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Erie Indemnity
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Ryan Specialty
2 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Erie Indemnity pays an annual dividend of $5.85 per share and has a dividend yield of 2.1%. Ryan Specialty pays an annual dividend of $0.52 per share and has a dividend yield of 1.1%. Erie Indemnity pays out 53.1% of its earnings in the form of a dividend. Ryan Specialty pays out 64.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Erie Indemnity has increased its dividend for 36 consecutive years and Ryan Specialty has increased its dividend for 1 consecutive years. Erie Indemnity is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Ryan Specialty beats Erie Indemnity on 11 of the 19 factors compared between the two stocks.

How does Ryan Specialty compare to Hagerty?

Ryan Specialty (NYSE:RYAN) and Hagerty (NYSE:HGTY) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

84.8% of Ryan Specialty shares are held by institutional investors. Comparatively, 20.5% of Hagerty shares are held by institutional investors. 52.0% of Ryan Specialty shares are held by company insiders. Comparatively, 3.7% of Hagerty shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Ryan Specialty has a net margin of 8.25% compared to Hagerty's net margin of 1.08%. Ryan Specialty's return on equity of 47.77% beat Hagerty's return on equity.

Company Net Margins Return on Equity Return on Assets
Ryan Specialty8.25% 47.77% 4.70%
Hagerty 1.08%6.27%1.92%

Ryan Specialty has a beta of 0.54, meaning that its stock price is 46% less volatile than the broader market. Comparatively, Hagerty has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market.

Ryan Specialty currently has a consensus target price of $52.91, suggesting a potential upside of 10.59%. Hagerty has a consensus target price of $16.43, suggesting a potential upside of 0.63%. Given Ryan Specialty's higher possible upside, research analysts clearly believe Ryan Specialty is more favorable than Hagerty.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ryan Specialty
1 Sell rating(s)
10 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.37
Hagerty
0 Sell rating(s)
5 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.38

Ryan Specialty has higher revenue and earnings than Hagerty. Ryan Specialty is trading at a lower price-to-earnings ratio than Hagerty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ryan Specialty$3.05B3.95$63.40M$0.8159.07
Hagerty$1.46B3.85$49.02M$0.06272.08

In the previous week, Hagerty had 4 more articles in the media than Ryan Specialty. MarketBeat recorded 12 mentions for Hagerty and 8 mentions for Ryan Specialty. Ryan Specialty's average media sentiment score of 0.63 beat Hagerty's score of 0.38 indicating that Ryan Specialty is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ryan Specialty
2 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hagerty
4 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Ryan Specialty beats Hagerty on 12 of the 16 factors compared between the two stocks.

Get Ryan Specialty News Delivered to You Automatically

Sign up to receive the latest news and ratings for RYAN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RYAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RYAN vs. The Competition

MetricRyan SpecialtyInsurance IndustryFinance SectorNYSE Exchange
Market Cap$12.06B$19.86B$13.84B$22.96B
Dividend Yield1.13%3.18%4.93%3.79%
P/E Ratio59.2021.3620.2129.23
Price / Sales3.961.955.003.29
Price / Cash14.3012.6220.2315.51
Price / Book13.412.201.793.63
Net Income$63.40M$1.80B$1.33B$1.08B
7 Day Performance1.88%-1.04%-1.94%-3.22%
1 Month Performance18.33%1.93%-1.49%-1.96%
1 Year Performance-15.10%10.18%5.07%6.74%

Ryan Specialty Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RYAN
Ryan Specialty
3.7785 of 5 stars
$48.03
+0.3%
$52.91
+10.2%
-15.2%$12.06B$3.05B59.206,110
AJG
Arthur J. Gallagher & Co.
3.5086 of 5 stars
$280.44
-0.4%
$292.05
+4.1%
+11.1%$73.91B$13.94B22.7372,000
BRO
Brown & Brown
3.0103 of 5 stars
$70.89
-1.7%
$75.47
+6.5%
-8.8%$24.51B$5.90B22.437,905
WTW
Willis Towers Watson Public
4.1847 of 5 stars
$327.01
-0.6%
$370.11
+13.2%
+5.0%$31.11B$9.71B17.9346,900
ERIE
Erie Indemnity
1.5118 of 5 stars
$270.52
-0.9%
N/A-3.7%$12.93B$4.07B29.536,667

Related Companies and Tools


This page (NYSE:RYAN) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners